APA (7th ed.) Citation

MK, B., KH, B., MK, V., GE, S., RA, K., JE, G., . . . SW, S. (2023). HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases. Journal of internal medicine, 293(5), 648. https://doi.org/10.1111/joim.13616

Chicago Style (17th ed.) Citation

MK, Brun, et al. "HLA-DQ2 Is Associated with Anti-drug Antibody Formation to Infliximab in Patients with Immune-mediated Inflammatory Diseases." Journal of Internal Medicine 293, no. 5 (2023): 648. https://doi.org/10.1111/joim.13616.

MLA (9th ed.) Citation

MK, Brun, et al. "HLA-DQ2 Is Associated with Anti-drug Antibody Formation to Infliximab in Patients with Immune-mediated Inflammatory Diseases." Journal of Internal Medicine, vol. 293, no. 5, 2023, p. 648, https://doi.org/10.1111/joim.13616.